Downregulation of GSTπ expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis-Reference-Cited by-同舟云学术

Downregulation of GSTπ expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis

Published:2009-06 Issue:5 Volume:20 Page:382-388
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Yu Sung-Tsai,Chen Tzer-Ming,Chern Ji-Wang,Tseng Shih-Yun,Chen Yen-Hui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference30 articles.

1. Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs;Krishna;Eur J Pharm Sci,2000

2. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research;Gottesman;FEBS Letters,2006

3. Mechanisms of drug resistance in cancer chemotherapy;Luqmani;Med Princ Pract,2005

4. Detoxification mechanisms and tumor cell resistance to anticancer drugs;Kuzmich;Med Res Rev,1991

5. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells;Batist;J Biol Chem,1986

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel 2-substituted 2, 3-dihydroquinazolin-4(1H)-one derivatives as tubulin polymerization inhibitors for anticancer therapy: The in vitro and in vivo biological evaluation;European Journal of Medicinal Chemistry;2024-11

2. Natural products for combating multidrug resistance in cancer;Pharmacological Research;2024-04

3. Discovery of the tryptanthrin‐derived indoloquinazoline as an anti‐breast cancer agent via ERK/JNK activation;Environmental Toxicology;2024-03-21

4. Recent advances of tryptanthrin and its derivatives as potential anticancer agents;RSC Medicinal Chemistry;2024

5. Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of in vitro anticancer activity, molecular docking, MD simulation and DFT studies;Journal of Biomolecular Structure and Dynamics;2023-05-25